Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

beta-Thalassemia 1Seizures 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neurofibromatosis 1 1Neuroblastoma 1Neoplasm, Residual 1Necrosis 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Acute 1Influenza, Human 1Hematologic Neoplasms 1Chromosome Aberrations 1Chromosome 7, monosomy 1Brain Neoplasms 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Specimen Handling 271Magnetic Resonance Spectroscopy 222pembrolizumab 216Carboplatin 175Biopsy 166Cisplatin 155Nivolumab 150Cyclophosphamide 135Paclitaxel 120Radiotherapy 117Gemcitabine 111Bevacizumab 93durvalumab 85Dexamethasone 83Rituximab 76Oxaliplatin 71atezolizumab 70Doxorubicin 67Capecitabine 67Fluorouracil 66venetoclax 65Etoposide 64Docetaxel 64Radiosurgery 58Radiation 57Cytarabine 57Prednisone 56Pemetrexed 55Ipilimumab 55Lenalidomide 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Levetiracetam × 90 days × Clear all
NCT01857934 2026-04-16

Therapy for Children With Advanced Stage Neuroblastoma

St. Jude Children's Research Hospital

Phase 2 Completed
153 enrolled 12 charts
CNS

Neuroblastoma

NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

NCT07130786 2026-03-19

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Brigham and Women's Hospital

Phase 2 Recruiting
150 enrolled
CNS

Brain Neoplasms, Necrosis, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡